Aadi Biosciences Inc (AADI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 6,179 | 5,353 | 6,326 | 5,959 | 6,202 |
| Cost of Goods | 778 | 652 | 927 | 697 | 656 |
| Gross Profit | 5,401 | 4,701 | 5,399 | 5,262 | 5,546 |
| Operating Expenses | 21,763 | 24,865 | 24,040 | 23,808 | 25,747 |
| Operating Income | -15,584 | -19,512 | -17,714 | -17,849 | -19,545 |
| Interest Expense | 58 | 58 | 57 | 58 | 58 |
| Other Income | 1,059 | 1,281 | 1,502 | 1,605 | 1,632 |
| Pre-tax Income | -14,583 | -18,289 | -16,269 | -16,302 | -17,971 |
| Net Income Continuous | -14,583 | -18,289 | -16,269 | -16,302 | -17,971 |
| Net Income | $-14,583 | $-18,289 | $-16,269 | $-16,302 | $-17,971 |
| EPS Basic Total Ops | -0.54 | -0.68 | -0.60 | -0.60 | -0.67 |
| EPS Basic Continuous Ops | -0.54 | -0.68 | -0.60 | -0.61 | -0.67 |
| EPS Diluted Total Ops | -0.54 | -0.68 | -0.60 | -0.60 | -0.67 |
| EPS Diluted Continuous Ops | -0.54 | -0.68 | -0.60 | -0.61 | -0.67 |
| EPS Diluted Before Non-Recurring Items | -0.54 | -0.68 | -0.60 | -0.60 | -0.67 |
| EBITDA(a) | $-15,922 | $-19,884 | $-18,156 | $-18,393 | $-20,364 |